Are Australians Able to Access New Medicines on the Pharmaceutical Benefits Scheme in a More or Less Timely Manner? An Analysis of Pharmaceutical Benefits Advisory Committee Recommendations, 1999

登录注册会员服务联系我们

Are Australians Able to Access New Medicines on the Pharmaceutical Benefits Scheme in a More or Less Timely Manner? An Analysis of Pharmaceutical Benefits Advisory Committee Recommendations, 1999–2003

Published:2006-07 Issue:4 Volume:9 Page:205-212
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Wonder Michael J.,Neville A. Munro,Parsons Richard

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference16 articles.

1. Drug policy down under: Australia's pharmaceutical benefits scheme;Duckett;Health Care Financ Rev,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of PBAC submissions and outcomes for medicines (2010–2018);International Journal of Technology Assessment in Health Care;2020-06

2. The Influence of Cost-Effectiveness Evaluations on Reimbursement in Australia: A Retrospective Study of Decisions made by the Pharmaceutical Benefits Advisory Committee;Pharmaceutical Medicine;2014-08

3. Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions;Health Policy;2012-12

4. A 3-Dimensional View of Access to Licensed and Subsidized Medicines under Single-Payer Systems in the US, the UK, Australia and New Zealand;PharmacoEconomics;2012-11

5. Using Economic Evaluation in Policy Decision-Making in Asian Countries: Mission Impossible or Mission Probable?;Value in Health;2009-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP